ANGILERI, LUISA

ANGILERI, LUISA  

Universita' degli Studi di MILANO  

Risultati 1 - 9 di 9 (tempo di esecuzione: 0.032 secondi).
Titolo Data di pubblicazione Autore(i) Tipo File Abstract
Clinical Response and Quality of Life in Patients with Severe Atopic Dermatitis Treated with Dupilumab : A Single-Center Real-Life Experience 1-mar-2020 Giovanni CasazzaLuisa AngileriSimona TavecchioFrancesca GerminiasiEmilio BertiAngelo Valerio MarzanoGiovanni Genovese + Article (author) -
Dupilumab and prurigo nodularis-like phenotype in atopic dermatitis : our experience of efficacy 2-set-2019 Tavecchio S.Berti E.Angileri L. + Article (author) -
Dupilumab therapy of atopic dermatitis of the elderly: a multi-centre, real-life study 1-apr-2021 Pigatto P. D.Angileri L.Damiani G. + Article (author) -
Effects of lockdown on health of patients with severe atopic dermatitis treated with dupilumab 1-gen-2020 Tavecchio S.Angileri L.Riva D.Romagnuolo M.Marzano A. V. + Article (author) -
Elevation of peripheral blood eosinophils during dupilumab treatment for atopic dermatitis is associated with baseline comorbidities and development of facial redness dermatitis and ocular surface disease 9-mar-2022 Angileri, LuisaTavecchio, SimonaCattaneo, DanieleMarzano, Angelo ValerioMaronese, Carlo Alberto + Article (author) -
Hookworm-related cutaneous larva migrans : our 201st patient 1-gen-2017 G. NazzaroL. AngileriS. Veraldi + Article (author) -
Safety and efficacy of dupilumab in a patient with severe atopic dermatitis and HIV infection, with 15 months of follow-up 1-gen-2020 Romagnuolo M.Angileri L.Tavecchio S.Marzano A. V. + Article (author) -
Safety of dupilumab in severe atopic dermatitis and infection of Covid-19 : two case reports 1-gen-2020 Romagnuolo M.Angileri L.Berti E.Tavecchio S. + Article (author) -
Seborrheic dermatitis and anti-COVID-19 masks 1-gen-2020 Veraldi S.Angileri L.Barbareschi M. Article (author) -